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We  investigated  the  effects  of  acute  valproate  (VPA)  on mouse  embryonic  primary  cortex  cells  (MEPCs).
Intracellular  ATP  concentrations  were  compared  with  changes  in  the  mean  action  potential  (AP)  frequen-
cies of  MEPC  networks  growing  on  microelectrode  arrays.  Our  data  implies  biphasic  reactions  towards
increasing  VPA  concentrations  for  both  parameters.  Intracellular  ATP  and  mean  AP  frequencies  increased
around  characteristic  concentrations  of 0.15 and  0.07 mM  to hormetic  plateaus  of approx.  120%  and  160%
of their  controls,  before  fading  around  17  and  1.7 mM,  respectively.  The  biphasic  in vitro behavior  of the
two  parameters  hinders  a simple  extraction  of  IC50 and  Hillslope  values.  Different  ways  of  data-ﬁtting
with  single  and  double  logistic  functions  are  discussed.  For  a typical  hormetic  increase  of  60%  above
control,  IC50 and  Hillslope  were  decreased  by  37%  and  15%, respectively.  Despite  these  marginal  effects
at  a logarithmic  concentration  scale,  the hormetic  and  double  logistic  behavior  of parameters  may  pro-ormesis vide  information  on the mode  of  action  of toxic  compounds.  Comparison  of our values  with the  LD50
of  mice,  recalculated  by normalization  to body  mass,  suggests  that a neurotoxic  rather  than  a cytotoxic
mechanism  is  killing  the  animals.  The  future  use  of cellular  microsystems  to replace  animal  experiments
will  motivate  the  development  of new  microsensors,  as  well  as  the  consideration  of newly  accessible
parameters  in  systems  biology  models.
© 2016  The  Authors.  Published  by  Elsevier  Ireland  Ltd.  This  is an open  access  article  under  the  CC  BY
license  (http://creativecommons.org/licenses/by/4.0/).. Introduction
To reduce, reﬁne and replace animal experiments (3R prin-
iple) is one of the major goals in current biomedical research.
ajor improvements have been achieved by using cellular assays
n speciﬁc ﬁelds such as vaccine testing (Kulpa-Eddy et al., 2011).
euronal cell cultures on chips with microelectrode arrays (MEA)
ave been used to detect the electric activity of neuronal networks
nd cardiac cells for more than 40 years (Gross et al., 1995, 1992,
985, 1977; Johnstone et al., 2010; Parenti et al., 2013; Thomas Jr.
t al., 1972). Currently, mouse embryonal primary cells (MEPCs) are
he gold standard for MEA  experiments (Koester et al., 2010 and
eferences cited therein). The method has potential applications
∗ Corresponding author.
E-mail addresses:
atthias.nissen@gmx.de (M. Nissen), buehler@fbn-dummerstorf.de (S.M. Buehler),
arco.stubbe@uni-rostock.de (M.  Stubbe), jan.gimsa@uni-rostock.de (J. Gimsa).
ttp://dx.doi.org/10.1016/j.biosystems.2016.04.009
303-2647/© 2016 The Authors. Published by Elsevier Ireland Ltd. This is an open access for the testing of neuroactive substances’ effects. It may  drasti-
cally reduce the need for animals, because approx. 2 × 107 cells
can be obtained from the embryos of a single gestating mouse and
100,000 to 300,000 cells are sufﬁcient to form an active neuronal
network on a MEA. There is hope that a further reduction in the
need of animals will become possible by the use of neurons derived
from human induced pluripotent stem cells (hIPSC) (Heikkilä et al.,
2009; Toivonen et al., 2013). Myocardiocytes derived from hIPSC
have already been used to investigate arrhythmia. In ﬁrst trials, the
method has been employed in the pretesting of drugs for individ-
ual patients. Nevertheless, reproducibility is still an issue for hIPSC
(Dick et al., 2010; Knollmann, 2013).
Valproate (VPA, Fig. 1) is a common synthetic drug for treating
neural disorders such as epilepsy or bipolar disorder (Johannessen,
2000). Information on VPA is readily available in the internet.
Because of its adverse effects in embryogenesis VPA is used as a
reference drug for in vitro tests of developmental neurotoxicity.
In the therapy of epilepsy, VPA administration results in average
blood-serum concentrations ranging from 50 to 100 g/ml, with
article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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sFig. 1. Chemical structure of sodium VPA.
axima of 150 g/ml (Sztajnkrycer, 2002). This corresponds to
pprox. 0.35–1.04 mM,  recalculated by assuming a body density
f 1 kg/l and the molar mass of VPA (144.21 g/Mol).
In 1992, Biggs et al. described a biphasic response (a decrease
ollowed by an increase) in the extracellular —aminobutyric
cid (GABA) concentration for increasing VPA concentrations in
he rat brain. In in vitro experiments with MEAs, VPA induced
 complementary behavior (an increase followed by a decrease)
n the neuronal activity around 0.05 mM (Johnstone et al., 2010;
cConnell et al., 2012). Several mechanisms have been suggested
or the effects of VPA, most of them resulting in an increase of the
ntracellular and extracellular GABA concentrations (Johannessen,
000; Sztajnkrycer, 2002). VPA is known to inhibit a number of
ABA-related enzymes, such as -ketoglutarate dehydrogenase,
hich degrades the GABA-precursor molecule -ketoglutarate in
he citric acid cycle (Luder et al., 1990). VPA is also known to inhibit
he succinat semialdehyd dehydrogenase and GABA transaminase
Whittle and Turner, 1978). While the ﬁrst mechanism should
esult in an increase of -ketoglutarate and consequently GABA
ynthesis, inhibition of the GABA transaminase and succinate semi-
ldehyde dehydrogenase will result in a reduced degradation of
ABA (Johannessen, 2000; Whittle and Turner, 1978). Neverthe-
ess, impairment of the citric acid cycle is also likely to have a direct
ffect on the energetic state of the cells, which can be detected using
ommercially available kits for the intracellular ATP concentration
Schoonen et al., 2005).
Another mechanism has been suggested for the direct inﬂuence
f VPA on the electric activity of neurons. In electric stimulation
xperiments with MEPCs, VPA was found to reduce the ﬁring prob-
bility registered in axons (McLean and Macdonald, 1986). Voltage
ated sodium and calcium channels were inhibited at therapeu-
ic concentrations of VPA leading to reduced maximum repetition
ates of APs together with lower average AP rates propagating
long axons (Johannessen, 2000; Kelly et al., 1990; McLean and
acdonald, 1986; Rinaldi et al., 2008; Zona and Avoli, 1990).
The mean AP frequency of neuronal networks is a well-
stablished parameter in the investigation of neurotoxic effects
Brischwein et al., 2003; Gray et al., 2001; Koester et al., 2010).
n scientiﬁc literature, different methods have been applied to
etermine IC50 values for VPA from MEA  experiments. Johnstone
t al. (2010) applied VPA under acute conditions to neuronal net-
orks of mouse MEPCs. The authors determined an IC50 of 1.7 mM
sing the same series of increasing concentrations in each network.
hen networks were forming by MEPCs subjected to permanent
xposure to certain VPA concentrations, the IC50 depended on
he duration of the culture, i.e.  their days in vitro (DIV). Koester
t al. (2010) described an IC50 of 0.76 mM after 12 DIV, which
as decreased to 0.33 mM after 21 DIV. After 12 DIV, the authors
ound that certain neurons with AP frequencies were signiﬁcantly
ncreased with respect to control in networks just below sub-lethal
PA concentrations. Interestingly, activity at this VPA concentra-
ion had ceased at 21 DIV, while again, neurons with very high AP
requencies were found just below sub-lethal VPA concentrations.
Here, we tested the effect of the acute VPA exposure of neuronal
etworks in a similar approach. Besides the mean AP frequency
f the networks, the intracellular ATP concentration was also
etected. Intracellular ATP is known as a measure for the energy
tatus, metabolic turnover and viability of cells (Leist et al., 1997;Fig. 2. 52-electrode MEA  with neuronal network grown from MEPCs.
Schoonen et al., 2005). To the best of our knowledge, the two
parameters have not yet been correlated for the same cell culture
conditions in a sufﬁciently large VPA concentration range, in order
to differentiate between cytotoxic and neurotoxic VPA effects.
As already described for chronic VPA exposure (Koester et al.,
2010), we expected an AP frequency increase at low VPA con-
centrations. Interestingly, we found a biphasic response in both
parameters, AP frequencies and intracellular ATP, with stimulat-
ing effects at low VPA concentrations followed by a ﬁnal decay
of the parameters. At the cellular level, similar responses have
been described for a number of parameters, which were increased
to up to 160% of their physiological standard values before their
ﬁnal decay (Calabrese, 2008). This “Paracelsus effect”, i.e.  beneﬁcial
effects of mild stress, is nowadays designated as “hormesis”, even
though the stimulating effects of low doses of toxic compounds
have been known for centuries and already described in detail by
Paracelsus (1538). In addition, toxic effects of nontoxic or medical
substances have been described when administered at excessive
doses.
Blackman (1905) described a biphasic temperature dependence
of the photosynthesis reaction with an optimum around 48 ◦C.
Even though cellular hormetic effects have often been mentioned
in scientiﬁc literature, discussion of them and their mathemati-
cal description is unsatisfactory (Buehler et al., 2011; Calabrese,
2008; Calabrese and Baldwin, 2001; Mattson, 2008; Ristow and
Schmeisser, 2011; Schmeisser et al., 2013; Stebbing, 1982, 1981).
This is probably one of the reasons why  hormesis is often neglected
in toxicology reports (compare to Hayess et al., 2013; Spielmann
et al., 2008). In this manuscript, we  present experiments that
show the hormetic behavior of the mean AP frequency and the
intracellular ATP concentration of neuronal networks under acute
VPA exposure. We  discuss the error in the determination of char-
acteristic concentrations, such as the IC50 values, resulting from
the hormetic, double logistic behavior. We  believe that a more
detailed analysis of the parameter dependence may  provide addi-
tional information on the underlying biochemical and physiological
mechanisms of the toxic effects.
2. Materials and methods
2.1. Surface preparationCustom made glass-neuro chips (GNCs) with a 52 electrode MEA
were used for the registration of neuronal APs (Fig. 2A). The GNCs
were produced by GeSiM (Gesellschaft für Silizium-Mikrosysteme
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bH, Grosserkmannsdorf, Germany; see Koester et al. (2010) for
etails).
New or re-used GNCs were cleaned using a 1% aqueous solution
f Tergazym® (Alcoconox, White Plains, NY, USA) at 37 ◦C for 1 h.
hen the chip surfaces were wiped with cotton swabs and rinsed
ith tap water before they were incubated in demineralized water
vernight. Finally, they were rinsed with pure ethanol (Carl Roth
mbH, Karlsruhe, Germany) and autoclaved before use.
To ensure comparability, glass surfaces were also used in the
TP experiments. For this, fresh, round cover slips of 10 mm diam-
ter (Carl Roth GmbH, Karlsruhe, Germany) were cleaned with pure
thanol. The cover slips ﬁtted in the wells of a 24 well plate (Greiner
io-One GmBH, Frickenhausen, Germany).
Chip and cover slip surfaces were coated following the same pro-
ocol. 50 l of 0.1 mg/ml  poly d lysine were pipetted to the center
f each surface and rinsed thrice with ultra-pure water after 1 h of
ncubation. Laminin was diluted with Dulbecco’s modiﬁed Eagle’s
edium (DMEM, Biochrom AG, Berlin, Germany) to a concentration
f 17 g/ml before 50 l of the solution were pipetted to the center
f each surface. After incubation at 37 ◦C for approx. 1 h, the solu-
ion was removed before cell seeding. If not speciﬁed otherwise, all
ubstances were purchased from Sigma Aldrich Laborchemikalien
mbH (Selze, Germany).
.2. Cell preparation and culture
The cells were cultured as previously described (Buehler et al.,
011; Koester et al., 2010). Gestating NMRI mice were obtained
8 days after mating from the “Animal house core facility” at the
niversity of Rostock, Germany. The mother animals were sacri-
ced via cervical dislocation before the embryos were prepared.
ll procedures were approved by the local animal care committee
nd are in accordance with the European Council Directive of 24
ovember 1986 (86/609/EEC).
The cortex of each embryo was dissected under sterile condi-
ions. To prevent the tissue from drying out, a dissection solution
as used. The 320-mOsm solution (pH 7.3) contained 10 mM HEPES
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid), 135 mM
aCl, 5.0 mM KCl, 0.3 mM Na2HPO4, 0.2 mM KH2PO4, 22.6 mM
ucrose, and 16.5 mM glucose.
The tissue was gently minced with a sterile scalpel and enzymat-
cally digested using the dissection solution supplemented with 10
nits/ml papain and 1.3 units/ml DNAse 1 (both from Roche Diag-
ostics GmbH, Mannheim, Germany) at 37 ◦C. 3 ml  of this solution
as sufﬁcient for 10 dissected cortices. After 10 min, digestion was
topped with 6 ml  preparation medium (carbonat buffered DMEM
upplemented with 10% horse serum, 10% fetal calf serum, 100 U/ml
enicillin, 100 g/ml streptomycin and 200 mM l-glutamine; all pur-
hased from Biochrom AG, Berlin, Germany).
The cells were spun down for 5 min  at 124 g and the supernatant
iscarded before they were triturated and diluted to a density
f 106 cells/ml with preparation medium. Approx. 150,000 and
0,000 cells were seeded per GNC or well of the 24-well plates,
espectively. After 1 h of incubation under cell culture conditions,
he GNC troughs and wells were ﬁlled with preparation medium
o total volumes of 270 l and 400 l, respectively. The cells were
ultured in an incubator with 10% CO2 at 95% humidity and a tem-
erature of 37 ◦C. Starting with the ﬁrst half-medium exchange
fter two days, the preparation medium was gradually replaced
y the cell culture medium without fetal calf serum (carbonate
uffered DMEM supplemented with 10% horse serum, 100 U/ml
enicillin, 100 g/ml streptomycin and 200 mM l-glutamine; all
urchased from Biochrom AG, Berlin, Germany) to fade-out glia
roliferation. Half-media exchanges were performed every second
ay. The cells formed networks on the MEAs and developed spon-
aneous electric activity with regular patterns after approx. threes 144 (2016) 35–45 37
weeks of culture. The electric activity remained stable for at least
six more weeks.
For experiments outside the incubator, the cell culture medium
was completely exchanged by a carbonate-independent, HEPES-
buffered measuring medium (HBM) with pH 7.3 and 340 mOsm.
It contained 137 mM NaCl, 5 mM KCl, 3 mM CaCl2, 0.1 mM  MgCl2,
0.01 mM glycine, 10 mM glucose, and 5 mM HEPES. For VPA mea-
surements, the HBM contained sodium VPA (http://echa.europa.
eu/de/substance-information/-/substanceinfo/100.002.525) in a
factor-of-three concentration series, ranging from 0.03 mM to
65.61 mM.
2.3. ATP assay
ATP assays (“ATPlite” kit, PerkinElmer Inc., Waltham, MA,  USA)
were performed according to the manufacturer’s protocol after 3
DIV. For measurements, cells were exposed to different VPA con-
centrations by replacing the culture medium in the wells with
VPA-containing HBM. After 15 min  at 37 ◦C, the solutions were
removed and the cells dissolved in the kit’s lysis buffer. The ATP-
related luminescence was  induced by addition of the kit’s reaction
buffer. 8 repeats were done for each VPA concentration and the
control without VPA. A LUMIstar luminescence micro plate reader
(BMG Labtech GmbH, Ortenberg, Germany) was used for lumines-
cence detection. For further details please see Buehler et al. (2011).
2.4. MEA signal detection
The spontaneous electric activity detected by the MEA  pads was
picked up by a home-made headstage (Koester et al., 2010) and fed
into a 64-channel ampliﬁer (Plexon Inc., Dallas, TX, USA). Up to 4
different AP waveforms could be separated per MEA  pad using the
principle component analysis tool of the MEA  Sort-Client software
(Plexon Inc., Dallas, TX, USA) and the AP traces could be separately
stored for each unit (Fig. 2B). Each unit was  assumed to originate
from an individual nerve cell (Thomas Jr. et al., 1972).
GNCs were individually removed from the incubator and pre-
pared for the MEA  experiment by exchanging the cell-culture
medium with HBM. GNCs were only used for experiments when
they exhibited eight or more active units after 10 min  of equili-
bration. Other chips were discarded. The electric activity measured
during the ﬁrst 15 min  was  deﬁned as “control”. After 15 min, the
VPA-free HBM was exchanged for HBM with one of the eight VPA
concentrations of the concentration series.
In pretests, Triton X100 was  used to terminate the GNC exper-
iments and to register the remaining ground noise of our setup,
which was  approx. ±4 VPP. In order to discriminate against noise
and to minimize the probability of registering false-positve AP
peaks, the threshold of AP registration was set to register only sig-
nals with negative ﬂanks initially falling below −5 V (see Fig. 2B).
2.5. Data analysis
ATP luminescence and AP frequency data was normalized to
the respective control averages and tested for outliers using the
Henning test (Raem and Rauch, 2006). All data was  ﬁtted using
OriginLab 8.1 or OriginLab 8.1 Pro (OriginLab Corporation, North
Hampton, MA USA) software. For statistical considerations and
graphs Sigmaplot 11 (Systat Software, Chicago, IL, USA) was  used.
The signiﬁcance levels were set to 5% in all tests. Before plotting
and statistical analysis, all data was normalized to 100% of the con-
trol average values of 111 relative units and 1.8 Hz for the ATP
luminescence and mean AP frequencies, respectively.
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Fig. 3. Screenshot of the Plexon sort client software registering 41 active units from the network shown in (Fig. 2). Left top: AP traces of three units at electrode pad 11
(encircled in Fig. 2). Left bottom: window for the principal component analysis with the three separated traces. Right: traces of 41 active units over 80 s. Each vertical dash
represents a single AP. Six major and one minor (the fourth) bursts (high frequency series of APs) can be clearly distinguished.
Fig. 4. Dependence of the intracellular ATP concentration (means ± standard errors)
on  VPA concentration. For a clearer presentation, the control localized outside of
the abscissa-concentration range was  plotted in a separate box. ATP concentrations
which were signiﬁcantly different from control are marked with one or two asterisks
(see Section 4). The single logistic function (Eq. (1)) was  ﬁtted to all data points
with the hormetic increase neglected (hm = 0%, dashed), ﬁxed to the average of the
hormetic data points (hm = 18.8%, dash-dotted), or as a free parameter (dotted). Eq.
(3) was used for a separate ﬁt of the increasing branch from control to the hormetic
plateau (hm = 18%, dash-dotted). The solid line is a ﬁt of Eq. (2). Fitted EC50 and IC50
c
t
r
3
s
t
T
p
t
0
(
e
Fig. 5. Dependence of the AP frequencies (means ± standard error) on VPA
concentration. For a clearer presentation, the control localized outside of the
abscissa-concentration range was plotted in a separate box. AP frequencies signiﬁ-
cantly different from control are marked with one or two asterisks (see Section 4).
The single logistic function (Eq. (1)) was ﬁtted to all data points with the hormetic
increase neglected (hm = 0%, dashed), ﬁxed to the average of the hormetic data points
(hm = 57%, dash-dotted), or as a free parameter (dotted). Eq. (3) was used for a sep-
arate ﬁt of the increasing branch from control to the hormetic plateau (hm = 57%,
dash-dotted). The solid line is a ﬁt of Eq. (2). Fitted EC50 and IC50 concentrations and
their corresponding mean AP frequency levels are marked by straight lines using the
Mouse embryonic primary cortex cells (MEPCs) may form elec-oncentrations and their corresponding ATP levels are marked by straight lines using
he  patterns of the related curves. Marked IC50 and EC50 values refer to the left and
ight  ordinates, respectively. All parameters are summarized in Table 1.
. Results
Pretests with the carbogen-buffered cell culture medium
howed a signiﬁcant medium evaporation caused the gassing of
he small cell culture-trough volume during MEA experiments.
herefore, we used HBM in the MEA  experiments. To ensure com-
arability, HBM was also used in the ATP experiments.
The dependence of the intracellular ATP on the VPA concen-
ration showed a slight increase above control between 0.27 and
.81 mM before the ﬁnal decay with an IC50 between 16 and 28 mM
Fig. 4). A similar increase has been found in the AP frequencies,
ven though at the lower VPA concentrations of 0.09 and 0.27 mMpatterns of the related curves. Marked IC50 and EC50 values refer to the left and right
ordinates, respectively. Please note the data point below ctrl at 0.03 mM just below
the hormetic increase (see Section 4). All parameters are summarized in Table 2.
before the ﬁnal decay with an IC50 between 0.6 and 2.0 mM (Fig. 5).
For details please see “data ﬁtting” in Section 4.
4. Discussion
4.1. Methods usedtrically active networks on microelectrode arrays (MEA) chips,
which can be used as biosensors for testing neuroactive compounds
(Gross et al., 1995, 1992, 1985, 1977; Johnstone et al., 2010; Parenti
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t al., 2013; Thomas Jr. et al., 1972). For such tests, valproate (VPA)
s an established reference compound (Gross et al., 1995; Johnstone
t al., 2010). Here we correlated the electric network activity with
he intracellular ATP concentration. The ATP test provided indepen-
ent information on the physiological cell state (Schoonen et al.,
005). We  suggest that VPA induced alterations in the intracellu-
ar ATP concentrations reﬂect cytotoxic effects, while alterations in
he mean AP frequencies reﬂect neurotoxic effects.
Interestingly, both parameters showed biphasic dependencies
n the VPA concentration with increases of the measuring parame-
ers followed by their ﬁnal decays. The stimulating effects observed
or ATP and AP frequencies largely correspond to the ideas of
alabrese (2008), who described a biphasic reaction as the most
ommon hormetic regime, though using slightly different param-
ter deﬁnitions. He described parameter increases to approx.
30–160% above control in a factor-20 dose range, i.e.  the range
etween the lowest dose at which stimulation was observed and
he approx. 20-fold concentration at which the hormetic increase
anished and the observed parameter reached the control level
efore its ﬁnal decay.
.2. Model-free statistics
The tricky part in the statistical validation of the hormetic
arameter behavior is to ﬁnd the right test for the experimental
ata; while strict tests will result in a higher conﬁdence in the
etected effects, minimizing the risk of false positive results, they
ncrease the probability of false negative results. For a more general
onsideration and to minimize the risk of both kinds of errors, three
ifferent tests were used for the statistical analysis of the data.
An initial test (one way ANOVA on ranks, p < 0.001) showed that
oth parameters were signiﬁcantly dependent on the external VPA
oncentration. Dunn’s method showed decreased ATP concentra-
ions at 21.29 and 65.61 mM VPA and decreased AP frequencies
rom 7.29 to 65.61 mM,  which were signiﬁcantly different from
ontrol (p < 0.05, marked by asterisks in Figs. 3 and 4). Nevertheless,
ccording to Dunn’s method, the data points of the intracellular
TP and AP frequencies, which were increased to approx. 120%
nd 157% compared to their respective controls, were insigniﬁ-
ant (p < 0.05). Therefore, we compared the likelihoods of a correct
escription of our data by single or biphasic (hormetic) logistic
unctions in a third test, using the Akaike information criterion (see
ection 4.6; Akaike, 1973).
.3. Models
The measuring data of ATP and AP frequencies were ﬁtted in
 number of ways in order to extract information on the relevant
inetic parameters. For the classical approach, a single logistic func-
ion was used:
1 (c) = min  +
ctrl + hm − min
1 +
(
c/IC50
)hs (1)
here ctrl + hm and min stand for the start plateau and the ﬁnal
lateau levels. Please note that this deﬁnition of the start plateau
evel allows the assumption of ctrl = 100%, though the start plateau
evel may  ﬂoat (hm /= 0%), or be ﬁxed to 100% (hm = 0%). IC50, c,
nd hs are the characteristic half maximum concentration, concen-
ration (independent measuring parameter), and the Hillslope of
he ﬁnal decay, respectively. For hm = 0, Eq. (1) becomes the well-
nown single logistic function which corresponds to the Lorentzian
quation used to describe electric dispersions (Lorentz, 1906). In
ase of hormesis, hm > 0 describes the offset to the 100%-control
evel.s 144 (2016) 35–45 39
Fits of Eq. (1) were compared with ﬁts of a double logistic func-
tion:
f2 (c) = min +
ctrl + hm − min
1 +
(
c/IC50
)hs − hm
1 +
(
c/EC50
)hs′ (2)
with the half maximum excitatory concentration EC50 and the
Hillslope of the hormetic increase hs’  contributing to a third sum-
mand. Eq. (2) provided an improved phenomenological description
of the data points. Under idealized conditions, the three terms
of Eq. (2) describe two Lorentzian transitions, the initial increase
from the starting plateau level ctrl to the hormetic plateau level
ctrl + hm around EC50 and the ﬁnal decrease to the minimum plateau
min around IC50. Nevertheless, for an insufﬁcient separation of the
two transition ranges, EC50, IC50, and hm are graphically not well-
deﬁned (compare to Fig. B1).
The ﬁts of the ATP or AP frequency data with Eq. (2) seem to
reﬂect these two quantitatively different cases; while the ﬁtted
values EC50, IC50, and plateau height for the ATP data correspond
to the intuitive behavior of the theoretical function (Fig. 4), this is
not the case for the AP frequencies data (Fig. 5). These differences
are caused by the signiﬁcant separation of the EC50 and IC50 values
(factor of approx.: 110) at a moderate theoretical plateau height for
the ATP data, and the insufﬁcient separation of the EC50 and IC50
values (factor of approx.: 3) at a much larger theoretical plateau
height for the AP frequencies data (for details please see Appendix
B).
For large discrepancies between the parameters obtained from
the nonlinear ﬁt and a straight-forward graphical extraction of the
parameters two possibilities may exist: (i) the EC50, IC50, and hm
values obtained by ﬁtting the data represent kinetic parameters of
the underlying biochemical or cytotoxic reactions, or (ii) no correla-
tion exists between these reactions and the parameters of a purely
phenomenological ﬁt.
For a closer look at this potential problem, the increasing (Eq. (3))
and decreasing (Eq. (1)) branches of the data were ﬁtted separately
(Figs. 3 and 4; columns 5 in Tables 1 and 2). The increasing branch
was obtained from Eq. (2) for concentrations much smaller than
IC50 (c « IC50):
f3 (c) = ctrl + hm −
hm
1 +
(
c/EC50
)hs′ (3)
For concentrations much larger than EC50, Eq. (2) converges to
Eq. (1). The IC50 values obtained from Eqs. (1) and (2) differ from
the values obtained at half maximal concentration, if hm > 0 (see
Appendix A for a more detailed analysis).
For hm > 0, the half maximal concentration IC50 obtained from a
“graphical solution” with respect to ctrl is generally different from
the value obtained from ﬁts of Eqs. (1) or (2) to all data points (see
Appendices 1 and 2). To obtain the abscissa concentration c = ICcor50
of the actual half-value between the ctrl and min  plateaus, corre-
sponding to the “graphical solution”, Eq. (1) must be solved for
f1(c) = (ctrl + min)/2:
ICcor50 = IC50 hs
√
ctrl + hm − min
(ctrl + min)/2 − min − 1 (4)
For min = 0% and ctrl = 100%, Eq. (4) is simpliﬁed to:
ICcor50 = IC50
hs
√
ctrl + hm
50
− 1 (5)
In comparison to the IC50 obtained from ﬁtting Eq. (1) for the
assumption of hm = 0, despite the measuring points above control
in the hormetic concentration range, ICcor50 improves the weighing
of the points at the ﬁnal decay ﬂank in the hs and IC50 determina-
tions. In principle, the ICcor50 can also be calculated from the IC50
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Table 1
Parameters obtained with four different methods of ﬁtting the ATP data in Fig. 4. For each method, the most relevant parameters are given in bold. The last line presents
“corrected” ICcor50 values, which correspond to a “graphical solution”, i.e.  the half plateau concentration between ctrl = 100% and min  = 0%. Accordingly, IC
cor
50 and IC50 correspond
(second column, ICcor50 given in parentheses). For details see Section 4.
Fitted parameters of
Fig. 4
Single logistic function
(Eq. (1)) with hm ﬁxed
or ﬁtted
Double logistic
function (Eq. (2))
Two  single logistic functions
separated for hormesis
(Eq. (3)) and decay (Eq. (1))
Line type Dashed Dotted Solid dash-dotted
ctrl  [%] ﬁxed: 100 ﬁxed: 100 ﬁxed: 100 ﬁxed: 100
Hormesis
hm  [%] ﬁxed: 0 4.46 ± 2.66 20.62 ± 4.77 ﬁxed: 18.8
EC50 [mM] 0.15 ± 0.08 0.15 ± 0.07
hs’  ﬁxed: 3 ﬁxed: 3
Decay
IC50 [mM] 28.43 ± 14.5 25.23 ± 3.44 16.58 ± 2.78 17.23 ± 2.63
hs  1.71 ± 0.82 1.42 ± 0.26 ﬁxed: 1 ﬁxed: 1
R2 0.74 0.74 0.78 hormesis: 0.37 decay: 0.66
ICcor50 values calculated with Eq. (5) (compare to Appendix A)
ICcor50 [mM]  (28.43) 26.79 23.41 23.7
Table 2
Parameters obtained with four different methods of ﬁtting the mean AP frequencies in Fig. 5. For each method, the most relevant parameters are given in bold. The last line
presents “corrected” ICcor50 values, which correspond to a “graphical solution”, i.e.  the half plateau concentration between ctrl = 100% and min  = 0%. Accordingly, IC
cor
50 and IC50
correspond (second column, ICcor50 given in parentheses). For details see Section 4.
Fitted parameters of
Fig. 5
Single logistic function
(Eq. (1))
with hm ﬁxed or ﬁtted
Double logistic
function (Eq. (2))
Two single logistic functions
separated for hormesis
(Eq. (3)) and decay (Eq. (1))
Line type Dashed dotted Solid dash-dotted
ctrl  [%] ﬁxed: 100 ﬁxed: 100 ﬁxed: 100 ﬁxed: 100
Hormesis
hm  [%] ﬁxed: 0 3.4 ± 7.8 158.68 ± 101.34 ﬁxed: 57
EC50 [mM] 0.11 ± 1.14 0.064 ± 0.067
hs’  ﬁxed: 3 ﬁxed: 3
Decay
IC50 [mM] 2.07 ± 0.89 1.95 ± 0.77 0.36 ± 0.24 0.78 ± 0.30
hs  1.38 ± 0.80 1.35 ± 0.77 ﬁxed: 1 ﬁxed: 1
R2 0.09 0.09 0.1 hormesis: 0.015 decay: 0
ICcor values calculated with Eq. (5) (compare to Appendix A)
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ICcor50 [mM]  (2.07) 2.04 
btained from Eq. (2). Nevertheless, for a strong overlap of the
ormetic increase with the ﬁnal decay, the result may  deviate from
he graphical solution (see Appendix B).
Generally, the ctrl-plateau level is well deﬁned by the control
ata. Nevertheless, a determination of the IC50 with ctrl + hm as a
ree parameter seems to be a compromise between ﬁtting Eq. (1)
or ctrl + hm = 100% and the ICcor50 methods. This compromise is often
sed in cellular toxicology (Hayess et al., 2013; Johnstone et al.,
010; Spielmann et al., 2008). For a comparison please see the IC50
nd ICcor50 values obtained from Eqs. (1), (2), and (5) in Tables 1 and 2.
Interestingly, the hormetic increase is well investigated at the
rganismic level in the ﬁelds of pharmacy and the abuse of drugs
Giancola and Zeichner, 1997). Hormesis is also considered in ani-
al  experiments (Bujanda, 2000; Waller et al., 1986; Weiss et al.,
993) and on the level of single enzymes (Cleland, 1963; Segel,
975). Nevertheless, the effect is often ignored in cellular toxico-
ogical essays (Hayess et al., 2013; Johnstone et al., 2010; Spielmann
t al., 2008). Surely, one reason is that a hormetic parameter
ncrease of magnitude hm is harder to detect than its ﬁnal decay
ith the signiﬁcantly larger magnitude of ctrl + hm − min.
For deﬁning the characteristic width (hmw) of the hormetic
ange, the EC50 provides a well-deﬁned low concentration (left)
oundary. Nevertheless, the right boundary is not as easy to deﬁne.
ven though the IC50 seems to be mathematically elegant, this def-
nition is somewhat unsatisfactory from a phenomenological point
f view (see Fig. B1). Here, we propose to use the parameter value1.46 1.65
of the EC50 concentration also at the decaying ﬂank for a deﬁnition
of the high concentration boundary. It can be determined from Eq.
(B1).
4.4. Data ﬁtting
For simplicity, min = 0 was  assumed in all ﬁts. For the intracel-
lular ATP concentration, min = 0 is obtained after subtracting the
ﬂuorescence blank values. The AP frequencies completely fade out
for dead cells or at very high VPA concentrations (Koester et al.,
2010).
In pretests, we  found that some ﬁts were not reliably conver-
gent in ﬁtting the Hillslopes, probably because of the low density
and natural variances in the measuring points at the increasing and
decaying ﬂanks. For this reason, the Hillslopes hs and hs’  were deter-
mined from test ﬁts of the increasing and decaying ﬂanks with Eqs.
(3) and (1), respectively (see Figs. 3, 4, and B1). The Hillslopes hs’
and hs describing the slopes of the increasing and decaying ﬂanks of
the intracellular ATP concentrations and AP frequencies data were
very similar according to visual assessments. While both hs’  values
were relatively steep, with values very close to three, both hs values
were shallower, with values of approx. unity. In the following con-
siderations on the hormetic effects, hs’  = 3 and hs = 1 were assumed.
An argument for this assumption is the robustness of the Hills-
lope parameter against changes in the initial plateau height (see
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nsert of Fig. A1). This simpliﬁcation allowed for a more consistent
omparison of the different ﬁtting methods.
Four different approaches were used to ﬁt each of the ATP and
P frequency data sets: in the ﬁrst approach Eq. (1) was used with
he start plateau level ﬁxed at ctrl + hm = 100% (hm = 0%). In a second
pproach, hm was ﬁtted. In the third approach, Eq. (2) was ﬁtted
or ctrl = 100%. In a fourth approach, the ctrl + hm levels were deter-
ined by averaging all data points above 100% and used in separate
ts of the increasing and decreasing branches with Eqs. (3) and (1),
espectively.
.5. Parameters obtained with different methods of data
nterpretation
The characteristic concentrations and plateau heights obtained
ith the four different methods of ﬁtting the experimental intracel-
ular ATP concentrations and mean AP frequencies are summarized
n columns 2 through 5 of Tables 1 and 2. The corresponding curves
re plotted in Figs. 3 and 4.
In an attempt to compare the ﬁtted parameters of Eqs. (1) and (2)
ith parameters, which are equivalent to intuitive “graphical” solu-
ions, e.g.  the half plateau concentration between ctrl + hm = 100%
or min  = 0%, Eq. (5) was used. With this approach, additional ICcor50
alues were obtained for each of the ﬁtted curves. The values
re given in the last lines of Tables 1 and 2. For the assump-
ion of ctrl + hm = 100% the “graphical solution” naturally leads to
Ccor50 = IC50.
In the ﬁrst method, a single logistic decay (Eq. (1)) was ﬁtted,
tarting from the 100%-control levels (columns 2 in Tables 1 and 2).
onstraining ctrl + hm in Eq. (1) to 100%, resulted in the highest IC50
alues of all four methods.
In the second method, three parameters of a single logistic decay
Eq. (1)), the IC50, the control levels ctrl + hm with ctrl = 100%, and
he Hillslopes hs were ﬁtted (columns 3 in Tables 1 and 2). Given
he presence of hormesis, this approach is theoretically unsatisfac-
ory, even though reasonable IC50 values were obtained. In this case,
ormetic measuring points above 100% resulted in ctrl + hm values
bove 100%. The obtained IC50 values were decreased with respect
o the ﬁrst method. The second approach is often applied in toxicol-
gy (Hayess et al., 2013; Seiler, 2002; Spielmann et al., 2008). In any
ase, the lower IC50 values will provide a higher toxicological safety
evel than values obtained with the ﬁrst method. Furthermore, the
ower number of model parameters will provide more stable ﬁts
nd easier reproducible parameters than Eq. (2), especially for low
umbers of measuring points or large scatters. From a toxicologi-
al point of view the approach complies with the idea of Ockham’s
azor (also known as “law of parsimony”; see Wikipedia). Never-
heless, the method neglects important information on biochemical
echanisms, which are expressed in the hormetic behavior.
In a third method, Eq. (2) was ﬁtted (columns 4 in Tables 1 and 2).
he three additional parameters hm, hs’  and EC50 with respect to Eq.
1) allow for the smoothest ﬁts of all measuring points. Despite of
he very good phenomenological description, it remains uncertain
hether the additional parameters of Eq. (2) may  be helpful in char-
cterizing biochemical or cell physiological mechanisms. It remains
o be elucidated whether the ﬁtted (Eq. (2)) or graphically extracted
arameters may  be helpful in characterizing the actual biochemical
r cell physiological background. Please see also Appendix B.
In a fourth method, Eq. (3) and (1) were separately ﬁtted to the
ncreasing and decreasing branches of the measuring data, respec-
ively (columns 5 in Tables 1 and 2). This method provides very
table ﬁts and may  help avoiding a possible over-interpretation
f the data with Eq. (2) when a mechanistic background for the
etected hormetic behavior is unlikely.s 144 (2016) 35–45 41
4.6. Likelihood comparison of models
The Akaike information criterion was used to compare the likeli-
hoods of Eq. (1) (hm ﬁxed) and Eq. (2) to correctly describe our data
(Akaike, 1973). We  found that the hormetic ﬁt (Eq. (2)) is clearly
better than the single logistic ﬁt (Eq. (1)) for both parameters (see
columns 2 and 4 in Tables 1 and 2). The likelihoods of the hormetic
models are 795.4 and 5.9 times higher for the ATP and AP frequency
data, respectively. We think that the main reason for this strong
discrepancy are the qualitatively different ﬁts of Eq. (2) to the two
data sets (see Appendix B). Please note that a comparison of Eq. (1)
with a ﬁtted initial plateau level (ctrl = 100%, hm /= 0%)  with Eq. (2)
assuming ctrl = 100% is not justiﬁed statistically.
4.7. Comparison of in vitro with in vivo parameters
To sum up, the IC50 values obtained from the ATP data varied
between 16.6 and 28.4 mM (Table 1), while the mean AP frequen-
cies showed a higher sensitivity with IC50 values varying between
0.36 and 2.07 mM (Table 2), depending on the ﬁtting method.
The ICcor50 values are more robust. They varied between 23.4 and
28.4 mM for the ATP data, as well as between 1.46 and 2.07 mM for
the AP frequencies. While the lower and upper limits of the IC50
values differed by factors of approx. 1.7 and 5.8 for the intracellu-
lar ATP and the AP frequencies, their ICcor50 limits differed only by
factors of approx. 1.2 and 1.4.
In medical reports (Sztajnkrycer, 2002) or for LD50 values of
animals (Carraz, 1968) Toxic VPA concentrations are given in ‘mg
substance per ml  blood serum’ or in ‘mg  substance per bodyweight’.
In order to compare our in vitro results with this data, we  converted
the literature data. While mg/ml  could simply be recalculated into
mM using the molecular mass of VPA, for the conversion of ‘mg
substance per bodyweight’ a body density of one kg/l was  assumed.
In rats, a biphasic inﬂuence of VPA on the GABA concentra-
tion has been described (Biggs et al., 1992). The minimal GABA
concentration was  reached at 200 mg/kg VPA corresponding to
an in vitro concentration of approx. 1.4 mM.  GABA concentration
changes could very well explain the effects measured in the neu-
ronal activity. McConnell et al. (2012) found a signiﬁcant increase
in the mean neuronal in vitro ﬁring rate at 0.05 mM VPA. Proba-
bly, these authors used an effective VPA concentration by chance
when they investigated a series of various neuro-active compounds
using the same concentrations. From subcutaneous experiments,
the LD50 in mice was found to be of 860 mg/kg (Carraz, 1968), which
we crudely recalculated to correspond to a concentration of approx.
6 mM IC50 values of approx. 1.7 mM have been published for the
neuronal activity of MEPCs on MEAs under acute administration of
VPA (Johnstone et al., 2010). This corresponds to our ICcor50 values
for the AP frequencies (Table 2).
4.8. On the mechanism of VPA action
The LD50 of 6 mM recalculated from Carraz (1968) lies just in
between the two  in vitro concentration ranges determined from
the intracellular ATP and the AP frequencies in our system. Never-
theless, in the case of VPA, we suppose that the IC50 value range
determined from the AP frequencies is more relevant for systemic
effects than ATP measurements are, especially because VPA may
permeate the blood-brain barrier. One direct neuronal VPA effect is
the inhibition of voltage dependent sodium and calcium channels,
thereby attenuating neuronal activity (Rinaldi et al., 2008; Zona and
Avoli, 1990).The systemic sensitivity towards VPA cannot be explained at
the enzymatic levels, e.g. by the properties of enzymes which are
known to be VPA targets, such as -ketoglutarate dehydrogenase
and several enzymes of the GABA degrading pathway (Johannessen,
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000; Luder et al., 1990; Sztajnkrycer, 2002; Whittle and Turner,
978). In both cases, VPA inhibition will lead to increasing GABA
oncentrations because -ketoglutarate is a substrate of GABA syn-
hesis.
Possibly, the IC50 range of the intracellular ATP concentration
ay be explained by the characteristic inhibitory concentration
f the -ketoglutarate dehydrogenase for VPA, which Whittle and
urner (1978) found to be between 38 and 85 mM.  Inhibition of
his enzyme will affect the citric acid cycle and directly reduce ATP
roduction (Johannessen, 2000). We  speculate that the increase in
he ATP concentration observed in the EC50 range results from a
ellular counter-regulation of the VPA effect.
Our ﬁndings make us believe that the main reason for the sys-
emic toxicity of VPA is based on its impact on the central nervous
ystem, while the impact on the citric acid cycle would be tolerable
elow the IC50 range of the intracellular ATP concentration.
.9. Hormesis—general discussion
In medicine, hormetic effects have been known for a long time.
his knowledge is reﬂected for example in the well-known state-
ent of Paracelsus (1538): “Everything is poison, and nothing
s without poison; the dose alone is what makes a thing non-
oisonous”. In classic toxicology, the characteristic lethal dose
LD50) is used for comparing the toxicity of substances. It is deﬁned
y the dose that 50% of the test subjects would not survive. While
ormetic behavior can hardly be investigated in LD50 experiments,
his is possible in in vitro experiments on cellular parameters.
Generally, hormesis can be seen as an overcompensating reac-
ion towards an adverse stimulus (Buehler et al., 2011; Belz and
iepho, 2011, 2015; Calabrese, 2008). For a parameter, which is kept
table by regulation in a biochemical or cell-physiological network,
 toxic substance at subcritical concentrations can be assumed to
nduce a parameter decrease, while slightly higher concentrations
ill generate over-compensation and a parameter increase. We
peculate that a VPA concentration of 0.03 mM may  have reduced
he “AP frequency” parameter before the up-regulation set in at
round 0.09 mM (Fig. 5). This speculation is backed by two argu-
ents. After introducing the independently determined Hillslopes
f hs’  = 3 and hs = 1 into Eq. (2), the 0.03 mM point ﬁtted perfectly,
o our surprise. Reduced parameters at concentrations just below
he hormetic increase have also been seen in other experiments
Buehler et al., 2011). The phenomenological reason for a ﬁrst min-
mum in Eq. (2) plot at the onset of hormesis is the low Hillslope
ssumed for the decreasing branch, resulting in a much wider
oncentration range being inﬂuenced by the decreasing than the
ncreasing branches (Fig. 5).
Nevertheless, if this interpretation is correct for a certain class
f parameters, there will be other parameter classes, which will
ot show a down-regulation before the onset of hormesis because
hey are not involved in the “sensory chain” of the affected regula-
ory network, or classes which are not affected at all, such as cell
dhesion for example (Buehler et al., 2011).
. Outlook
Toxic substances can induce greater neuronal activity, as seen
n epilepsy treatment or with seizures-inducing substances (Jiruska
t al., 2010). Nevertheless, the neuronal activity is usually ignored in
oxicological in vitro studies, which aim at extrapolating LD50 from
C50 values (Hayess et al., 2013; Johnstone et al., 2010). In terms
f toxicology, ﬁtting Eq. (1) with hm as a free parameter requires
he least number of assumptions and results in robust IC50 val-
es. Nevertheless, the pharmacokinetics in the affected organisms
s important for a comparison with LD50 data.s 144 (2016) 35–45
Our IC50 values for VPA are in the range of literature data
(Johnstone et al., 2010; Koester et al., 2010). In medical treat-
ments, the effect of VPA is fast, with lag times under 5 min after
administration (Johannessen, 2000). In its protonated form, VPA
may  easily cross the blood-brain barrier (Krämer and Walden,
2013). These properties make VPA a model substance for compar-
ing the data obtained from in vivo experiments and crude in vitro
systems. Databases on the effects of neuroactive substances are cur-
rently build by different workgroups (see for example: McConnell
et al., 2012; Schroeder et al., 2008). The data is interesting in pre-
clinical tests, which will be especially important in the medicine
for an aging society. Here, MEA  can be used in the investigation
of interferences of different medicaments with patient-speciﬁc
hIPSC.
However, a more detailed picture of the biochemical and
cell physiological mechanisms requires the registration of ADME
(absorption, distribution, metabolism, and excretion) processes
(Van de Waterbeemd and Gifford, 2003). Additional sensors for
speciﬁc cell markers or released metabolites are desirable for this;
especially when the interplay of multiple cell species, resembling
the complex biotransformation processes in mammalian organ-
isms needs to be registered.
Currently, in in vitro systems, only integrative parameters are
detectable with the existing sensors, for example pH, oxygen, cer-
tain substances such lactate or even purely physical parameters,
like electric impedances. The integrative nature of these param-
eters imposes foreseeable problems in systems biology modeling
and the future animal replacement by cellular micro systems. To
bridge this gap, a future goal of systems biology should be the devel-
opment of models for the interpretation of the accessible sensor
data. Models for the metabolic behavior of networks of speciﬁc cell
types, for example in the apoptosis of liver cells, are a ﬁrst step into
this direction (Philippi et al., 2009).
We  suppose that hormetic effects will be important in future
model considerations. In terms of hormesis, the increase in AP
frequency as well as the root length of germinating plant seeds
may  potentially exceed the 160% limit proposed for the metabolic
in vitro parameters (Belz and Piepho, 2012; Calabrese, 2008).
Low doses of adverse substances are known to occur in the envi-
ronment, e.g. resulting from the use of pesticides or the excretion
of medicaments. In the ﬁeld of ecotoxicology, low concentrations
of diluted drugs may  be of high importance (Seiler, 2002). Interest-
ingly, low doses of adverse substances may  expand the life span of
organisms (Ristow and Schmeisser, 2011; Schmeisser et al., 2013).
One interesting conclusion is that biological systems are contin-
uously exposed to low doses of toxic compounds or radiation.
Therefore, it cannot be ruled out that organisms are usually in a
kind of “hormetic mode” towards certain substances and the con-
version of in vitro data will be biased for ubiquitous toxins or their
mimicking compounds.
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Fig. B1. Considerations on the ﬁt of the AP frequency dependence. The solid line
curve corresponds to the ﬁt of Eq. (2) in Fig. 5. The dotted line curves are sepa-
rated plots of the increasing (from ctrl to ctrl + hm) and decreasing branches (from
ctrl  + hm to min = 0%) of Eq. (2). The straight lines marking the EC50 and IC50 values are
oriented to the left and right ordinates, respectively. The dotted lines mark the the-
oretical EC50 and IC50 values of Eq. (2). The graphical 50% values between the ctrl and
ctrl + hmh as well as between the ctrl + hm and min  = 0% plateaus are marked by solid
lines. The ICcor50 value (Table 2, second column) is marked by a dashed line. Absolute
values of hm and ctrl, as well as the hormetic plateau offset (hmh) obtained from the
graphical solution are marked with vertical double arrows. Two possible deﬁnitions
for  the hormetic plateau width (hmw) are indicated with horizontal double arrows.
Table B1
Comparison of the ctrl + hm, IC50, and EC50 values obtained from Eq. (2) ﬁts of the AP
frequencies with the graphical parameters of Fig. B1.
Fitted parameters (mean ± SE) Graphical value
ctrl [%] 100 (ﬁxed) 100
hm [%] 158.68 ± 101.3 69.0 (hmh)
EC50 [mM]  0.07 ± 0.02 0.07
IC50 [mM]  0.36 ± 0.24 0.7
ICcor50 1.46 1.55
hs  1 (ﬁxed)
hs’  3 (ﬁxed)
hmw (factors between top double arrow: 4.14M. Nissen et al. / BioS
erent models. Robert Sleigh (Sleigh Technical Translations, Berlin,
ermany) is acknowledged for his help with the manuscript. M.N.
s grateful for a scholarship of the German Research Foundation
DFG, Research Training Group 1505/1 and 2 “welisa”).
ppendix A.
Inﬂuence of a biphasic kinetic on the determination of IC50 and
illslope values.
In toxicological experiments, data points above the control val-
es are often observed at substance concentrations below the
C50 of the parameters under test. The parameter increase at low
ubstance concentrations, followed by a ﬁnal decrease at high
oncentrations, is called ‘biphasic’ or ‘hormetic’ and should be
ccounted for in the exact determination of IC50 and hm values
f these parameters. Because the ﬁnal decay of the ﬁtting curve
tarts from a plateau level above the control of 100% in the presence
f hormesis, the increased ‘half-maximum plateau levels’ will be
eached at lower concentrations and result in reduced IC50 values.
In the simplest case, Eq. (1) can be used to ﬁt a single logistic
ecay or the declining branch beyond a wide hormesis plateau, as
een in the ATP data (Fig. 4). To estimate the inﬂuence of an increase
n the start plateau on the ﬁtted IC50, we used simulated data. For
easons of simplicity, the ﬁnal minimum was assumed to be 0%. To
ake sure that all curves reﬂect the same experimental behavior
round and below the 50% height of the reference curve without
ormesis (bold curve in Fig. A1), theoretical points taken from this
ranch of the reference curve were ﬁtted with Eq. (1) assuming
trl + hm values varying between 100% and 200% (Fig. A1). The R2
alues for all ﬁts were higher than 0.99. As a result, the ICcor50 val-
es of all curves are independent from the increasing hormetic
lateau levels and corresponded with the IC50 of the reference
urve. For increasing plateau heights, decreasing IC50 and hs val-
es were obtained in the simulation. For ctrl + hm = 200% the IC50
alue was decreased by a factor of approx. 0.51 while the Hillslope
as reduced from 2.0 to approx. 1.63 (insert of Fig. A1).
Because the experimentally observed hormetic increases of var-
ous parameters are generally not exceeding levels of 160% above
ontrol (Calabrese, 2008), the possible erroneous decrease in the
etermined IC50 values will be moderate. Toxicologically speaking,
he decreasing IC50 values obtained for increasing hormetic heights
ould tolerably improve the safety margins.
ig. A1. Simulated curves obtained from Eq. (1) under the assumption of hormetic
tart-plateau levels of ctrl + hm = 100% (ctrl = 100%, hm = 0%, bold reference curve),
20%, 140%, 160%, 180% and 200% (ctrl = 100%, hm = 100%), respectively. The corre-
ponding IC50 concentrations are marked by dashed lines starting with a bold dashed
ine for ctrl + hm = 100% (reference). The insert shows the obtained IC50 and hm val-
es in dependence on the start plateau levels. The curves are touching the ordinates
left  or right) they refer to.low and high
concentration margins)
bottom double arrow: 11.6
Appendix B.
Is the discrepancy in the mathematical and graphical plateau
heights in Fig. 5 a model artifact or does it have a biological back-
ground?
Interestingly, the ﬁts of the ATP and AP frequency data with
Eq. (2) reﬂect two qualitatively different cases; while the ﬁtted
EC50 and IC50 values and hormetic plateau heights correspond to
the intuitive behavior of the theoretical function for the ATP data
(Fig. 4), this is not the case for the AP frequency data (Figs. 5 and B1).
The reason for the qualitative difference is the signiﬁcant separa-
tion of the EC50 and IC50 values by a factor of 110 at a moderate
hormetic plateau level of ctrl + hm = 119% for the ATP data, con-
trasting to the insufﬁcient factor-of-3 separation of the EC50 and
IC50 values in combination with an overshooting hormetic plateau
level of ctrl + hm = 259% for the AP frequency data (Figs. 5 and B1).
The AP frequency behavior is described by not well sepa-
rated, counteracting increasing and decreasing sigmoidal branches,
which exhibit a strong overlap in the hormetic plateau region.
This overlap results in the apparent discrepancy of the parameters
obtained from ﬁtting Eq. (2) and the “graphical” parameters, appar-
ently reﬂecting the plot of Eq. (2) (columns 2 and 3 of Table B1).
While ﬁtting Eq. (2) leads to ctrl + hm = 259% the function plot
exhibits a graphical plateau height of ctrl + hmh  = 169% (Fig. B1).
For this discrepancy, two  opposing interpretations are possible,
(i) the parameters of the ﬁt reﬂect the kinetics of some underly-
ing biochemical or cytotoxic reactions, or (ii) Eq. (2) provides a
simple (probably the simplest) mathematical description for a phe-
nomenological parameter dependence by coincidence. With our
current knowledge, the two  possibilities cannot be distinguished.
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Fig. B1 also illustrates possible deﬁnitions of parameters for the
henomenological description of the hormetic behavior. For the
haracteristic hormetic range width (hmw) two possible deﬁnition
re indicated by horizontal double arrows. While the left boundary
s deﬁned by the EC50 in both cases, the right boundary may  either
e deﬁned by the IC50 or the parameter value of the EC50 concentra-
ion at the decaying ﬂank. In this case, the characteristic hormetic
idth ranges from EC50 to EC ′50:
C ′50 = IC50 hs
√
ctrl + hm − min
hmh/2  + ctrl − min − 1 (B1)
Please note that this equation was obtained from Eq. (1) for
1(c) = hmh/2 + ctrl and may  deviate from an exact solution for
trongly overlapping increasing and decreasing branches of Eq. (2).
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